A case of niraparib PARP-Inhibitor induced Sweet Syndrome in gynecologic cancerCase Report Published on 2023-03-152024-09-04 Journal: Gynecologic Oncology Reports [Category] 대상포진, [키워드] adverse effects Niraparib ovarian cancer PARPi Sweet syndrome [DOI] 10.1016/j.gore.2023.101162 PMC 바로가기 [Article Type] Case Report
Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating womenarticle Published on 2023-01-112024-09-05 Journal: International Breastfeeding Journal [Category] update2024, [키워드] adverse effects antibodies breast milk Breastfeeding maternal immunity neonatal immunity SARS-CoV-2 vaccine [DOI] 10.1186/s13006-022-00536-y PMC 바로가기 [Article Type] article
An EUA for anakinra (Kineret) for COVID-19Article Published on 2022-12-122023-07-11 Journal: The Medical letter on drugs and therapeutics [Category] COVID19(2023년), [키워드] actemra adverse effects Anakinra Baricitinib Corticosteroids COVID-19 Dexamethasone dosage Drug interactions Efficacy lactation Olumiant Pregnancy Remdesivir Safety Tocilizumab Veklury
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical managementArticle Published on 2022-12-012022-11-16 Journal: Endocrine [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] adjuvant adverse effects age Autoimmune autoimmune thyroiditis benefit Clinical management clinician described disease Diseases Doppler Factor Fever Follow-up Genetic genetic susceptibility grave Graves’ disease homology inactivated Inflammatory inflammatory markers men molecular mRNA-based Neck pain palpitation pandemic pathogenic mechanism Patient patients patients with SARS-CoV-2 predisposition Protein reported SARS-CoV-2 SARS-CoV-2 protein SARS-CoV-2 vaccination SARS-CoV-2 vaccines silent Subacute Subacute thyroiditis symptoms onset syndrome Thyroid Thyroiditis Treatment vaccination Vaccine Vaccines women [DOI] 10.1007/s12020-022-03118-4 PMC 바로가기
Miller Fisher syndrome following COVID-19 vaccines: A scoping reviewArticle Published on 2022-11-012022-11-16 Journal: Acta neurologica Scandinavica [Category] 변종, [키워드] adverse effects adverse event AEs antibody COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 vaccination COVID-19 vaccine Diagnosis Fisher Fisher syndrome Guillain-barrè syndrome identify incidence material Miller Miller fisher syndrome neurological nine pathophysiology Patient Region reported syndrome systematic review the MEDLINE vaccine administration variant [DOI] 10.1111/ane.13687 PMC 바로가기
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protectionArticle Published on 2022-10-152022-11-15 Journal: Journal of Biomedical Science [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, [키워드] adverse effects analyzed biological basis booster clinical impact COVID-19 COVID-19 vaccine COVID-19 vaccines death effective Effectiveness immune correlate Immunity knowledge pandemic potential mechanism provided public health reduced regimen researcher risk SARS-CoV-2 SARS-CoV-2 strains SARS-CoV-2 variant SARS-CoV-2 variants severe adverse events the SARS-CoV-2 virus Vaccine Vaccines variant virus with COVID-19 [DOI] 10.1186/s12929-022-00853-8 PMC 바로가기
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsArticle Published on 2022-10-012022-11-15 Journal: Transfusion [Category] COVID19(2023년), SARS, 진단, [키워드] 28-day mortality acute respiratory syndrome administration adverse effects adverse event adverse events antibody antibody assay Antibody Response Antibody titers Antigen assays binding case-control study CCP Characteristics characterization Control Controlled trial convalescent convalescent plasma coronavirus COVID-19 COVID-19 convalescent plasma died disease severity Donor donors enrolled evaluated group had no heterogeneous hospital Hospitalized immune response Immunosuppressed median median age Microarray NAb Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing antibody assays neutralizing capacity not affect pathogen-reduction treatment. Patient Pneumonia recipient recipients response responses SARS CoV-2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV2 single-center survival symptom onset transfused transfusion treated Treatment variable with COVID-19 [DOI] 10.1111/trf.17083 PMC 바로가기
Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trialArticle Published on 2022-09-202022-11-16 Journal: Trials [Category] SARS, 변종, [키워드] acute lung injury acute respiratory distress addition adverse effects antibody applied ARDS Aviptadil baseline Clinical improvement clinical status Concentration conducted COVID-19 COVID-19 in patient COVID-19 patient defined double-blinded Efficacy and safety Europe exclusion criteria FIVE hemodynamic instability high risk homeostasis hospital discharge Hospitalization immunomodulating IMPROVE indicate Inhaled intensive care intestinal intravenously lung lung tissue management mechanical ventilation metabolism Mortality multicenter Multicenter trial pandemic Pathways Patient patients hospitalized peptide placebo-controlled Prevent primary endpoint pro-inflammatory Prognosis Protein Public Hospital Randomized randomized trial Randomly reduction Regulation respiratory complication Risk factors SARS-CoV-2 severe disease course shown standard care stratified Study protocol suggested syndrome the SARS-CoV-2 therapeutic agent Therapies therapy Treatment unique vaccination Vaccine variants of SARS-CoV-2 Vasoactive VIP VIP. with COVID-19 World Health Organization [DOI] 10.1186/s13063-022-06723-w PMC 바로가기
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?Article Published on 2022-09-172022-11-15 Journal: International Journal of Molecular Sciences [Category] SARS, 유전자 메커니즘, 진단, [키워드] adverse effects Antigen complex conventional vaccines COVID-19 COVID-19 mRNA vaccine Dice drug Effect emergency condition Evidence implication mechanism of action mRNA mRNA vaccine mRNA vaccines Pharmacodynamics pharmacokinetic pharmacokinetics Pharmacology representing resulting S protein Safe Safety Safety assessment SARS-CoV-2 SARS-CoV-2 S protein Spike protein the SARS-CoV-2 took place translation undergo understanding vaccination [DOI] 10.3390/ijms231810881 PMC 바로가기
MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapiesMiRNA-SARS-CoV-2 대화 및 전향적인 항-COVID-19 치료법Review Published on 2022-09-152022-09-11 Journal: Life sciences [Category] COVID19(2023년), MERS, SARS, 바이오마커, 변종, 비임상, 진단, 치료기술, 치료제, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 adverse effect adverse effects Affect antiviral response approach approved Biomarker caused Cell signaling chance Clinical significance Comorbidities coronavirus Coronavirus-2 country COVID-19 COVID-19 illness COVID-19 infection COVID-19 pathogenesis COVID-19 patient Critical death detect differential expression disease disease onset disease pathology effort etiology expression FDA focus Host host cell host inflammatory response host miRNA host miRNAs identify Infection life cycle microRNA miRNA miRNAs molecular interaction non-coding RNA offer pathogen Pathogen-host interaction patients with COVID-19 post-transcriptionally quest reduce respiratory respond RNA RNA silencing SARS Coronavirus SARS coronavirus 2 SARS coronavirus 2. SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants SARS-CoV-2 virus Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severity Signaling target gene the SARS-CoV-2 virus therapy treat Treatment Viral viral miRNA viral miRNAs [DOI] 10.1016/j.lfs.2022.120761 PMC 바로가기 [Article Type] Review